Inventory gain and loss, clear countermeasures, plan the new bureau company to deploy the next stage of production and operation work
Release time:
2021-04-21
News from our newspaper 2021 is the first year of the national "14th Five-Year Plan", and it is also an important year for the company to further deepen reforms and accelerate the pace of development. 4# April 15 and 16 , the company successively held work analysis meetings for pharmaceutical sector, cement sector and directly affiliated enterprises to summarize and take stock of the work gains and losses in the first quarter, requirements for this year's follow-up work, especially in the second quarter. At the
analysis meeting, the person in charge of each enterprise reported the work situation in the first quarter, focused on analyzing the existing problems, and put forward solutions and improvement plans. In the first quarter of this year, the impact of the new crown virus pneumonia epidemic in various parts of the country to varying degrees, the subordinate enterprises in seriously do a good job in the prevention and control of the epidemic at the same time, efforts to do a good job in production and operation, maintenance and technical reform, the work carried out in a smooth and orderly manner. At the work analysis meeting, chairman Jiang Xiaomeng, general manager Yu Jianhong and other group company leaders commented on the work of each business sector one by one in combination with the economic and technical data of each enterprise in the first quarter, pointed out the highlights of the work, analyzed the problems and deficiencies, and put forward guidance and work requirements on how to further improve the work quality in the second three quarters of this year.
Peak Pharmaceutical Industry: Adjusting Thinking, Mending Shortcomings, Promoting Promotion
In view of various changes brought about by the reform of the national medical system in recent years and the current overall situation of the peak pharmaceutical industry, the meeting requires that the management of pharmaceutical companies should make more systematic plans for future work from the perspective of strategic development and constantly change their inherent thinking while doing a good job in daily production and operation management, find and make up for the short board of work, look for the gap against advanced enterprises, and constantly improve and upgrade. In terms of sales, it is necessary to carefully analyze the industry impact of centralized drug procurement and the country's in-depth rectification of the pharmaceutical industry, increase the innovation and reform of sales models and methods, closely track and timely evaluate current sales policies, and increase the control of market sales. Intensity. In terms of product research and development, while actively promoting the work related to consistency evaluation, it is necessary to further accelerate the construction of research and development platforms and continuously introduce new products with competitive advantages. As an important API base in the company's pharmaceutical sector, North Carolina and its subsidiaries should strengthen team building, unify thinking, unify actions, improve overall organizational capabilities and system management and control capabilities, and do each job carefully. City pharmaceutical companies and large pharmacies two pharmaceutical circulation enterprises, to do a stable sales, while paying attention to market changes, to seek breakthrough opportunities.
Cement Plate: Overall Control, Practice Internal Skills, Seize Opportunities
Affected by multiple factors, cement markets around the world have fluctuated to varying degrees since this year. In view of this situation, the meeting requires that the three cement enterprises under the company should further change their existing cognition and management concepts on the basis of their previous work, fully understand the gap between themselves and the excellent enterprises in the same industry, comprehensively improve their quality and ability from management cadres to ordinary employees, and achieve comprehensive control of the whole work process; constantly promote the application of digital and intelligent management means, continuously improve the reliability and stability of equipment and the effective operation rate of the system, and comprehensively improve labor productivity; strengthen the awareness of safety production, and grasp the management of safety and environmental protection; further optimize the organizational structure, improve the management level, practice internal skills, and create advantages, Seize development opportunities.
According to the specific conditions of various cement enterprises, the meeting required that Daye Peak should pay attention to the stability of the system operation after low-carbon transformation, do a good job in the preliminary preparation of the mechanism sand project, extend the industrial chain, and create new benefit growth points; Yunnan Peak should speed up the work related to mine remediation, do a good job in the production connection after the transformation of raw mill, further strengthen the production site remediation, and improve the stability and reliability of equipment operation, further strengthen marketing management to stabilize prices and markets; As a new enterprise, Huang Ping Jianfeng should do a good job in the quality management of mine raw materials, continuously optimize the batching scheme and cement grinding process parameters, reduce the clinker consumption of finished products, continuously improve and stabilize the product quality, reasonably carry out market planning, formulate effective marketing strategies according to the specific conditions of different regions, and improve the profitability of the enterprise.
In view of the new cement development project, the company requires to do a good job in promoting the relevant work to lay a good foundation for future development.
Peak Health: Clear the current situation, focus on the key points, and strive to break through
Peak Health Technology Company 2021 implemented a new round of management personnel contracting. After a quarter of work, obvious changes have been made and various operating indicators have improved. The meeting required the peak health management team to size up the situation, implement accurate policies, and strengthen market expansion and adjustment of marketing strategies. Subsequent product development should also focus on market channels and customer requirements, and carry out extended development while steadily improving existing market sales. Clarify the work direction, improve the overall management efficiency, earnestly implement the national management policy for health products, and operate in accordance with the law.
International Trade Company: Strengthen management, improve efficiency and control risks
In view of the operation and current business composition of international trade companies in the first quarter, the meeting requested international trade companies to strengthen coordination and management with enterprises entering the park, do a solid job in fire safety management of logistics parks, and provide the most basic guarantee for the operation and development of enterprises. Improve the standard of work management requirements, do a good job in the coordinated operation of the new information system and the original NC and dispatching system; Make good use of the government's support policies to speed up the construction of network logistics and car-free freight transportation platform; Continuously expand and introduce new business varieties to increase varieties to improve the overall business operation ability; Further increase the proportion of direct business and improve profitability; Strengthen the control of foreign trade business sectors and pay attention to preventing exchange rate risks; strengthen the application of modern management means and tools to promote the improvement of labor productivity.
Cable Company: Improve Quality, Reduce Cost, Improve Benefit
Cable Company achieved good operating results in the first quarter, and the overall operating conditions have improved significantly. The meeting asked cable companies to further strengthen equipment management in view of the current situation of the cable market, comprehensively improve the management level and technical level, while improving and stabilizing product quality, reduce costs by reducing the failure rate and unnecessary loss; pay close attention to the market price fluctuation of copper and other major raw materials, and follow the market to avoid market risks; seriously study the market and improve the ability to obtain information, efforts to improve domestic sales, direct sales and professional market sales, improve profitability, and strive for greater benefits.
(Reporter)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page